Two Japanese Generic Drugs Found To Deviate From Standards
This article was originally published in PharmAsia News
Executive Summary
Two generic drugs used in Japan were found to have deviated from specified standard and have been recalled, according to the annual generic drug quality assurance survey conducted by Japan's Ministry of Health, Labor and Welfare in 2008. The two products, Nippro's cilostazol and Isei's nifedipine were found to have different standards than specified by their manufacturing and marketing approvals. Both makers have since voluntarily recalled the products. The Ministry said no adverse effects were reported. A total of 876 generic products marketed in Japan were tested in the last year. (Click here for more - Japanese language